Cannabinoids
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
63
NCT00944801
Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
Phase: Phase 1/2
Role: Collaborator
Start: Jul 31, 2002
Completion: May 31, 2009
Loading map...